# US 2017/0285004 A1 · Systems and Methods for Targeted Therapy Based on Single-Cell Stimulus Perturbation Response

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0285004 A1
- Document ID: US20170285004A1
- Status: Published application
- Kind: A1
- Application number: 15/480,327
- Filed: 2017-04-05
- Published: 2017-10-05
- Earliest claimed: 2016-04-05
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Benedict Anchang; Sylvia K. Plevritis
- Web page: https://patentgrep.com/patent/US20170285004A1

## CPC

- G01N 33/5011: {for testing antineoplastic activity}
- G01N 33/56966: {Animal cells}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 5/20: Probabilistic models
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods for targeted therapy based on single-cell stimulus perturbation response. In one embodiment, a method for optimizing stimulus combinations for therapy includes receiving a cell sample, treating the cell sample with a plurality of stimuli by treating a different portion of the cell sample with one of the plurality of stimuli for each of the plurality of stimuli, labeling the cell sample with a plurality of metal-conjugated probes, analyzing the cell sample using a mass spectrometer, obtaining mass spectrometry data from the mass spectrometer, identifying subpopulations within the cell sample using the mass spectrometry data, computing stimulus effects, generating a nested-effects model using the mass spectrometry data, and scoring stimuli combinations using the computing device, wherein the stimulus combinations are combinations made from the plurality of stimuli.

## Claims

### Claim 1

A method for optimizing stimulus combinations for therapy, the method comprising:
receiving a cell sample;
treating the cell sample with a plurality of stimuli by treating a different portion of the cell sample with one of the plurality of stimuli for each of the plurality of stimuli;
labeling the treated cell sample with a plurality of metal-conjugated antibodies, wherein the plurality of metal-conjugated antibodies corresponds with a set of markers;
analyzing the labeled cell sample using a mass spectrometer;
obtaining mass spectrometry data from the mass spectrometer, wherein the mass spectrometry data describe perturbation responses;
identifying subpopulations within the cell sample using the mass spectrometry data using a computing device;
computing stimulus effects using the mass spectrometry data using the computing device;
generating a nested-effects model using the mass spectrometry data and the stimulus effects using the computing device, wherein the nested-effects model describes the relationships between the plurality of stimuli and the set of markers across the subpopulations;
scoring stimulus combinations using the nested-effects model using the computing device, wherein the stimulus combinations are combinations made from the plurality of stimuli; and
outputting a list of ranked stimulus combinations based on the scored stimulus combinations.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nested-effects model is represented as a directed graph.

### Claim 3 (depends on 1)

The method of claim 1, wherein the stimulus effects are computed using Bayesian linear models.

### Claim 4 (depends on 1)

The method of claim 1, wherein the set of markers comprises at least one lineage marker and at least one intracellular signaling marker, wherein the subpopulations are identified using the at least one lineage marker.

### Claim 5 (depends on 4)

The method of claim 4, wherein the set of markers further comprises at least one death marker, wherein the method further comprises removing apoptotic cell data from the mass spectrometry data for cells that are committed to apoptosis using the at least one death marker.

### Claim 6 (depends on 5)

The method of claim 5, wherein the apoptotic cell data are removed and the subpopulations are identified using a decision tree.

### Claim 7 (depends on 1)

The method of claim 1, wherein the stimulus combinations are scored based on minimizing the amount of stimuli in the stimulus combination while maximizing a desired effect.

### Claim 8 (depends on 1)

The method of claim 1, wherein scoring the stimulus combinations take into account side effects of the stimulus combinations.

### Claim 9 (depends on 1)

The method of claim 1, the stimulus effects are computed with weightings using prior knowledge.

### Claim 10 (depends on 1)

The method of claim 1, wherein the subpopulations are identified through manual gating.

### Claim 11

A system for optimizing stimulus combinations for therapy, the system comprising:
a processor;
a mass spectrometer;
a memory connected to the processor and configured to store an application, wherein the application configures the processor to:
obtain mass spectrometry data from the mass spectrometer, wherein the mass spectrometry data describe perturbation responses of a cell sample labeled with a plurality of metal-conjugated antibodies corresponding to a set of markers;
identify subpopulations within the cell sample using the mass spectrometry data;
compute stimulus effects using the mass spectrometry data;
generate a nested-effects model using the mass spectrometry data and stimulus effects, wherein the nested-effects model describes the relationships between the plurality of stimuli and the set of markers across the subpopulations;
score stimulus combinations, wherein the stimulus combinations are combinations made from the plurality of stimuli; and
output a list of ranked stimulus combinations based on the scored stimulus combinations.

### Claim 12 (depends on 11)

The system of claim 11, wherein the nested-effects model is represented as a directed graph.

### Claim 13 (depends on 11)

The system of claim 11, wherein the stimulus effects are computed using Bayesian linear models.

### Claim 14 (depends on 11)

The system of claim 11, wherein the set of markers comprises at least one lineage marker and at least one intracellular signaling marker, wherein the subpopulations are identified using the at least one lineage marker.

### Claim 15 (depends on 14)

The system of claim 14, wherein the set of markers further comprises at least one death marker, wherein the processor is further configured to remove apoptotic cell data from the mass spectrometry data for cells that are committed to apoptosis using the at least one death marker.

### Claim 16 (depends on 15)

The system of claim 15, wherein the apoptotic cell data are removed and the subpopulations are identified using a decision tree.

### Claim 17 (depends on 11)

The system of claim 11, wherein the stimulus combinations are scored based on minimizing the amount of stimuli in the stimulus combination while maximizing a desired effect.

### Claim 18 (depends on 11)

The system of claim 11, wherein scoring the stimulus combinations take into account side effects of the stimulus combinations.

### Claim 19 (depends on 11)

The system of claim 11, wherein the stimulus effects are computed with weightings using prior knowledge.

### Claim 20 (depends on 11)

The system of claim 11, wherein the subpopulations are identified through manual gating.
